Guided Therapeutics (GTHP) Current Leases (2019 - 2025)
Guided Therapeutics recorded quarterly Current Leases of $45000.0 in Q4 2025, down 40.79% quarter-over-quarter from $76000.0 in Q3 2025, and down 57.55% year-over-year from $106000.0 in Q4 2024.
Guided Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $45000.0 for Q4 2025.
- In Q4 2025, Current Leases fell 57.55% year-over-year to $45000.0; the TTM figure through Dec 2025 stood at $45000.0 (down 57.55% YoY), while the FY2025 annual figure was $45000.0, down 57.55% from the prior year.
- Current Leases came in at $45000.0 for Q4 2025 at Guided Therapeutics, down from $76000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $110000.0 in Q1 2025 to a low of $42000.0 in Q1 2021.
- A 5-year average of $80800.0 and a median of $80500.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases slumped 57.58% in 2021 and soared 66.67% in 2022, its largest moves.
- Guided Therapeutics' Current Leases stood at $67000.0 in 2021, then rose by 17.91% to $79000.0 in 2022, then increased by 15.19% to $91000.0 in 2023, then climbed by 16.48% to $106000.0 in 2024, then tumbled by 57.55% to $45000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $45000.0, $76000.0, and $104000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 35.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 88,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Sep 30, 2022 | 76,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 64,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Dec 31, 2020 | 56,000.00 |
| Sep 30, 2020 | 57,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Mar 31, 2020 | 99,000.00 |
| Dec 31, 2019 | 103,000.00 |
| Sep 30, 2019 | 88,000.00 |
| Jun 30, 2019 | 103,000.00 |
| Mar 31, 2019 | 105,000.00 |